Joanna Luczkowiak
Majadahonda, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
Superior neutralizing response after first versus second SARS-CoV-2 infection in fully vaccinated individuals.
Journal: Journal of medical virology
Published: August 02, 2023
Preclinical immune efficacy against SARS-CoV-2 beta B.1.351 variant by MVA-based vaccine candidates.
Preclinical immune efficacy against SARS-CoV-2 beta B.1.351 variant by MVA-based vaccine candidates.
Journal: Frontiers in immunology
Published: July 20, 2023
Dendritic Cell-Mediated Cross-Priming by a Bispecific Neutralizing Antibody Boosts Cytotoxic T Cell Responses and Protects Mice against SARS-CoV-2.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: July 16, 2023
The role of DC-SIGN as a trans-receptor in infection by MERS-CoV.
Journal: Frontiers in cellular and infection microbiology
Published: March 01, 2023
Immune Response Against SARS-CoV-2 Infection and Vaccination in a CD8α-Deficient Patient.
Journal: Journal of clinical immunology
Published: February 15, 2023
TLR7 Activation in M-CSF-Dependent Monocyte-Derived Human Macrophages Potentiates Inflammatory Responses and Prompts Neutrophil Recruitment.
Journal: Journal of innate immunity
Published: November 08, 2022
Cross neutralization of SARS-CoV-2 omicron subvariants after repeated doses of COVID-19 mRNA vaccines.
Journal: Journal of medical virology
Published: August 20, 2022
Intranasal administration of a single dose of MVA-based vaccine candidates against COVID-19 induced local and systemic immune responses and protects mice from a lethal SARS-CoV-2 infection.
Journal: Frontiers in immunology
Published: July 15, 2022
Cellular and humoral immune responses and breakthrough infections after three SARS-CoV-2 mRNA vaccine doses.
Journal: Frontiers in immunology
Published: June 29, 2022
Last Updated: 09/26/2026